Paper2175676
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.
Scheffner M and 4 others. Cell, 1990. Cited by 3,724 papers, by iCite.
Cite this record
ConductScience Library. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Papers, record 2175676. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2175676
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA-Binding Proteins | Major topic |
| Oncogene Proteins, Viral | Major topic |
| Papillomaviridae | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Antigens, Polyomavirus Transforming | |
| Blotting, Western | |
| Endopeptidases | |
| Humans | |
| Protein Binding | |
| Protein Biosynthesis | |
| RNA, Messenger | |
| Transcription, Genetic | |
| Ubiquitins |
Source PubMed
Cited by1,557
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,724 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959994 | Altered immune responses in HR-HPV infected women. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42959994 | PubMed |
| 42931222 | Human Papillomavirus and Prostate Cancer: A Controversial Association. | Pathogens | 2026 | https://conductscience.org/library/papers/42931222 | PubMed |
| 42907449 | Short-term memory of past caspase activity biases cell elimination in vivo. | Nat Commun | 2026 | https://conductscience.org/library/papers/42907449 | PubMed |
| 42900416 | The neolignan Miliusin B inhibits cell migration and promotes apoptotic cell death in cervical cancer cell line HeLa. | Med Oncol | 2026 | https://conductscience.org/library/papers/42900416 | PubMed |
| 42888274 | From HPV infection to cervical precancer: Molecular mechanisms, immune microenvironment and emerging technologies. | Cell Mol Life Sci | 2026 | https://conductscience.org/library/papers/42888274 | PubMed |
| 42864353 | Functional characterization of viral transcriptional regulators reveals extensive rewiring of host pathways. | Nat Commun | 2026 | https://conductscience.org/library/papers/42864353 | PubMed |
| 42856810 | Cancer degronopathies and protein-fate biomarkers in drug resistance and cancer progression: signalling mechanisms, measurement and translational limits. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42856810 | PubMed |
| 42842293 | Herpes simplex virus type 2 induces S-phase entry and arrest to regulate the cell cycle for efficient replication. | J Gen Virol | 2026 | https://conductscience.org/library/papers/42842293 | PubMed |
| 42836275 | Manipulation of the cell cycle by HIV-1. | Biochem Soc Trans | 2026 | https://conductscience.org/library/papers/42836275 | PubMed |
| 42818333 | Single-cell analysis identifies TOP2α as a critical regulator of G2/M entry and differentiation-dependent productive HPV replication. | bioRxiv | 2026 | https://conductscience.org/library/papers/42818333 | PubMed |
| 42769609 | Beyond approval: a mechanism-based review of novel anti-tumour agents in cervical cancer and when to use them. | Front Immunol | 2026 | https://conductscience.org/library/papers/42769609 | PubMed |
| 42752189 | Regulation and function of the HPV16 CircE7 RNA. | J Virol | 2026 | https://conductscience.org/library/papers/42752189 | PubMed |
| 42720426 | Establishment of Stable Immortalized Human Choroidal Melanocytes for Ocular Research. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42720426 | PubMed |
| 42699170 | Endolysosomal routing combined with immune stimulation enhances anti-tumor efficacy of an HPV16 mRNA therapeutic vaccine. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42699170 | PubMed |
| 42688650 | Human papillomavirus-related oral lesions in people with HIV: A 20-year multinational cohort analysis. | J Dent Sci | 2026 | https://conductscience.org/library/papers/42688650 | PubMed |
| 42589670 | Evaluation of HER2 and Nectin-4 Expression in Primary Vaginal Cancers. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589670 | PubMed |
| 42589374 | Proteomic Analysis of TCGA Data Reveals Limited Prognostic Value of p53 but Suggests BAX as a Potential Survival Marker in Cervical Carcinoma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589374 | PubMed |
| 42554752 | Viral persistence and host-state remodeling in virus-associated cancers. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42554752 | PubMed |
| 42545015 | The polymerase milieu of human papillomavirus. | J Virol | 2026 | https://conductscience.org/library/papers/42545015 | PubMed |
| 42429056 | New insights into the physiological, pathological and pharmacological roles of voltage‑gated potassium channel Kv10.1 in cancer (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/42429056 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TP53 | 7157 | Swiss-Prot's references | https://conductscience.org/library/genes/7157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2175676
GET https://conductscience.org/api/papers/v1/2175676/cited_by?page=2